{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:03:38Z","timestamp":1784765018418,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":64,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008376","name":"Helsingin ja Uudenmaan Sairaanhoitopiiri","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008376","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005634","name":"Suomen Hammasl\u00e4\u00e4k\u00e4riseura Apollonia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005634","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Finnish association for women dentists, Finland"},{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007417","name":"Paulon S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007417","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The tumor microenvironment is regulated by matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs); however, their utility as cancer biomarkers remains unclear. We investigated the associations of serum MMP-8, TIMP-1, and the MMP-8\/TIMP-1 ratio with prevalent and incident cancer in 8448 individuals aged 25\u201374 years from the FINRISK97 cohort. Participants were followed for incident cancer (n\u2009=\u20091618) for 26 years through the Finnish Cancer Registry. Serum MMP-8 and TIMP-1 concentrations were measured at baseline using immunoassays. Serum TIMP-1 levels were significantly higher in individuals with prevalent and incident cancer, including colorectal and lung cancer, whereas lower MMP-8 levels were observed in colorectal and prostate cancer. Accordingly, the MMP-8\/TIMP-1 ratio was reduced in individuals with incident cancer. In age-stratified models adjusted for sex, smoking, and BMI, elevated TIMP-1 levels were strongly associated with incident cancer in participants aged 55\u201364 years (HR, 95% CI 6.36, 2.50\u201316.16) and\u2009\u2265\u200965 years (6.23, 1.67\u201323.21), and with cancer mortality (29.7, 8.25\u2013106 and 18.4, 3.64\u201393.6). MMP-8 and the MMP-8\/TIMP-1 ratio showed weaker associations with incident cancer and cancer mortality only in the 45\u201354-year age group. These findings support TIMP-1 as a potential biomarker for cancer risk and mortality.<\/jats:p>","DOI":"10.1038\/s41598-026-52354-5","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T07:34:25Z","timestamp":1779262465000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum TIMP-1 concentrations are associated with cancer incidence and cancer-related mortality in a population-based cohort"],"prefix":"10.1038","volume":"16","author":[{"given":"M. T.","family":"Nieminen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. S.","family":"Havulinna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Kambur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Tervahartiala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Zeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Blankenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Salomaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Sorsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. J.","family":"Pussinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Salminen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"52354_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. Cancer J. Clin. 74, 229\u2013263 (2024).","journal-title":"CA. Cancer J. Clin."},{"key":"52354_CR2","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1039\/C4CS00370E","volume":"44","author":"L Wu","year":"2015","unstructured":"Wu, L. & Qu, X. Cancer biomarker detection: Recent achievements and challenges. Chem. Soc. Rev. 44, 2963\u20132997 (2015).","journal-title":"Chem. Soc. Rev."},{"key":"52354_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1042\/bse0380021","volume":"38","author":"Y Itoh","year":"2002","unstructured":"Itoh, Y. & Nagase, H. Matrix metalloproteinases in cancer. Essays Biochem. 38, 21\u201336 (2002).","journal-title":"Essays Biochem."},{"key":"52354_CR4","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nrc745","volume":"2","author":"M Egeblad","year":"2002","unstructured":"Egeblad, M. & Werb, Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2, 161\u2013174 (2002).","journal-title":"Nat. Rev. Cancer"},{"key":"52354_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/0118715206270002231108071917","volume":"24","author":"S Maurya","year":"2024","unstructured":"Maurya, S., Prasad, D. & Mukherjee, S. Matrix metalloproteinases in oral cancer pathogenesis and their use in therapy. Anticancer Agents Med. Chem. 24, 3\u201317 (2024).","journal-title":"Anticancer Agents Med. Chem."},{"key":"52354_CR6","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1186\/s12885-018-4589-x","volume":"18","author":"C B\u00f6ckelman","year":"2018","unstructured":"B\u00f6ckelman, C. et al. Serum MMP-8 and TIMP-1 predict prognosis in colorectal cancer. BMC Cancer 18, 679 (2018).","journal-title":"BMC Cancer"},{"key":"52354_CR7","doi-asserted-by":"publisher","first-page":"3853","DOI":"10.1007\/s00018-011-0763-x","volume":"68","author":"H Hua","year":"2011","unstructured":"Hua, H., Li, M., Luo, T., Yin, Y. & Jiang, Y. Matrix metalloproteinases in tumorigenesis: An evolving paradigm. Cell. Mol. Life Sci. 68, 3853\u20133868 (2011).","journal-title":"Cell. Mol. Life Sci."},{"key":"52354_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23010146","volume":"23","author":"S Niland","year":"2021","unstructured":"Niland, S., Riscanevo, A. X. & Eble, J. A. Matrix metalloproteinases shape the tumor microenvironment in cancer progression. Int. J. Mol. Sci. 23, 146 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"52354_CR9","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00726-010-0689-x","volume":"41","author":"T Klein","year":"2011","unstructured":"Klein, T. & Bischoff, R. Physiology and pathophysiology of matrix metalloproteases. Amino Acids 41, 271\u2013290 (2011).","journal-title":"Amino Acids"},{"key":"52354_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","volume":"141","author":"K Kessenbrock","year":"2010","unstructured":"Kessenbrock, K., Plaks, V. & Werb, Z. Matrix metalloproteinases: Regulators of the tumor microenvironment. Cell 141, 52\u201367 (2010).","journal-title":"Cell"},{"key":"52354_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25010527","volume":"25","author":"G Fornieles","year":"2023","unstructured":"Fornieles, G., N\u00fa\u00f1ez, M. I. & Exp\u00f3sito, J. Matrix metalloproteinases and their inhibitors as potential prognostic biomarkers in head and neck cancer after radiotherapy. Int. J. Mol. Sci. 25, 527 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"52354_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21249739","volume":"21","author":"GA Cabral-Pacheco","year":"2020","unstructured":"Cabral-Pacheco, G. A. et al. The roles of matrix metalloproteinases and their inhibitors in human diseases. Int. J. Mol. Sci. 21, 9739 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"52354_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20184506","volume":"20","author":"K Juurikka","year":"2019","unstructured":"Juurikka, K., Butler, G. S., Salo, T., Nyberg, P. & \u00c5str\u00f6m, P. The role of MMP8 in cancer: A systematic review. Int. J. Mol. Sci. 20, 4506 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"52354_CR14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10555-006-7893-x","volume":"25","author":"R Chirco","year":"2006","unstructured":"Chirco, R., Liu, X.-W., Jung, K.-K. & Kim, H.-R.C. Novel functions of TIMPs in cell signaling. Cancer Metastasis Rev. 25, 99\u2013113 (2006).","journal-title":"Cancer Metastasis Rev."},{"key":"52354_CR15","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1002\/cncr.22637","volume":"109","author":"A Lipton","year":"2007","unstructured":"Lipton, A. et al. Elevated plasma tissue inhibitor of metalloproteinase-1 level predicts decreased response and survival in metastatic breast cancer. Cancer 109, 1933\u20131939 (2007).","journal-title":"Cancer"},{"key":"52354_CR16","first-page":"6267","volume":"59","author":"G Li","year":"1999","unstructured":"Li, G., Fridman, R. & Kim, H. R. Tissue inhibitor of metalloproteinase-1 inhibits apoptosis of human breast epithelial cells. Cancer Res. 59, 6267\u20136275 (1999).","journal-title":"Cancer Res."},{"key":"52354_CR17","doi-asserted-by":"publisher","first-page":"899","DOI":"10.3109\/00365521.2013.812235","volume":"48","author":"M Grunnet","year":"2013","unstructured":"Grunnet, M., Mau-S\u00f8rensen, M. & Br\u00fcnner, N. Tissue inhibitor of metalloproteinase 1 (TIMP-1) as a biomarker in gastric cancer: A review. Scand. J. Gastroenterol. 48, 899\u2013905 (2013).","journal-title":"Scand. J. Gastroenterol."},{"key":"52354_CR18","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1093\/ije\/dyp330","volume":"39","author":"E Vartiainen","year":"2010","unstructured":"Vartiainen, E. et al. Thirty-five-year trends in cardiovascular risk factors in Finland. Int. J. Epidemiol. 39, 504\u2013518 (2010).","journal-title":"Int. J. Epidemiol."},{"key":"52354_CR19","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3109\/02841869409098430","volume":"33","author":"L Teppo","year":"1994","unstructured":"Teppo, L., Pukkala, E. & Lehtonen, M. Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol. 33, 365\u2013369 (1994).","journal-title":"Acta Oncol."},{"key":"52354_CR20","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1097\/EDE.0000000000001630","volume":"34","author":"R Denz","year":"2023","unstructured":"Denz, R. & Timmesfeld, N. Visualizing the (causal) effect of a continuous variable on a time-to-event outcome. Epidemiology 34, 652 (2023).","journal-title":"Epidemiology"},{"key":"52354_CR21","first-page":"1311","volume":"20","author":"S Ylisirni\u00f6","year":"2000","unstructured":"Ylisirni\u00f6, S., H\u00f6yhty\u00e4, M. & Turpeenniemi-Hujanen, T. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer\u2013TIMP-1 as a prognostic marker. Anticancer Res. 20, 1311\u20131316 (2000).","journal-title":"Anticancer Res."},{"key":"52354_CR22","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1038\/s41598-025-85549-3","volume":"15","author":"A Kehusmaa","year":"2025","unstructured":"Kehusmaa, A. et al. Associations of serum and tissue TIMP1 with host response and survival in colorectal cancer. Sci Rep 15, 1440 (2025).","journal-title":"Sci Rep"},{"key":"52354_CR23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3892\/ol.2012.691","volume":"4","author":"BS Min","year":"2012","unstructured":"Min, B. S., Kim, N. K., Jeong, H. C. & Chung, H. C. High levels of serum VEGF and TIMP-1 are correlated with colon cancer liver metastasis and intrahepatic recurrence after liver resection. Oncol. Lett. 4, 123\u2013130 (2012).","journal-title":"Oncol. Lett."},{"key":"52354_CR24","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s10555-019-09812-6","volume":"38","author":"C Eckfeld","year":"2019","unstructured":"Eckfeld, C., H\u00e4u\u00dfler, D., Schoeps, B., Hermann, C. D. & Kr\u00fcger, A. Functional disparities within the TIMP family in cancer: Hints from molecular divergence. Cancer Metastasis Rev. 38, 469\u2013481 (2019).","journal-title":"Cancer Metastasis Rev."},{"key":"52354_CR25","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1186\/s12885-017-3842-z","volume":"17","author":"S Blanco-Prieto","year":"2017","unstructured":"Blanco-Prieto, S. et al. Relevance of matrix metalloproteases in non-small cell lung cancer diagnosis. BMC Cancer 17, 823 (2017).","journal-title":"BMC Cancer"},{"key":"52354_CR26","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/bjc.1994.336","volume":"70","author":"T Baker","year":"1994","unstructured":"Baker, T. et al. Serum metalloproteinases and their inhibitors: Markers for malignant potential. Br. J. Cancer 70, 506\u2013512 (1994).","journal-title":"Br. J. Cancer"},{"key":"52354_CR27","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.70047","volume":"12","author":"S Almuntashiri","year":"2024","unstructured":"Almuntashiri, S. et al. Estrogen-dependent gene regulation: Molecular basis of TIMP-1 as a sex-specific biomarker for acute lung injury. Physiol. Rep. 12, e70047 (2024).","journal-title":"Physiol. Rep."},{"key":"52354_CR28","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20210911","volume":"218","author":"CD Hermann","year":"2021","unstructured":"Hermann, C. D. et al. TIMP1 expression underlies sex disparity in liver metastasis and survival in pancreatic cancer. J. Exp. Med. 218, e20210911 (2021).","journal-title":"J. Exp. Med."},{"key":"52354_CR29","first-page":"287","volume":"20","author":"J-H Lee","year":"2011","unstructured":"Lee, J.-H., Choi, J.-W. & Kim, Y.-S. Plasma or serum TIMP-1 is a predictor of survival outcomes in colorectal cancer: A meta-analysis. J. Gastrointestin. Liver Dis. 20, 287\u2013291 (2011).","journal-title":"J. Gastrointestin. Liver Dis."},{"key":"52354_CR30","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1177\/1724600819866202","volume":"34","author":"M Vo\u010dka","year":"2019","unstructured":"Vo\u010dka, M. et al. Serum levels of TIMP-1 and MMP-7 as potential biomarkers in patients with metastatic colorectal cancer. Int. J. Biol. Markers 34, 292\u2013301 (2019).","journal-title":"Int. J. Biol. Markers"},{"key":"52354_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4055-9","volume":"18","author":"O Prokopchuk","year":"2018","unstructured":"Prokopchuk, O. et al. Elevated systemic levels of the matrix metalloproteinase inhibitor TIMP-1 correlate with clinical markers of cachexia in patients with chronic pancreatitis and pancreatic cancer. BMC Cancer 18, 128 (2018).","journal-title":"BMC Cancer"},{"key":"52354_CR32","doi-asserted-by":"publisher","first-page":"E463","DOI":"10.1002\/ijc.26435","volume":"131","author":"JP V\u00e4yrynen","year":"2012","unstructured":"V\u00e4yrynen, J. P. et al. Serum MMP-8 levels increase in colorectal cancer and correlate with disease course and inflammatory properties of primary tumors. Int. J. Cancer. 131, E463-474 (2012).","journal-title":"Int. J. Cancer."},{"key":"52354_CR33","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1111\/j.1582-4934.2011.01302.x","volume":"15","author":"J Decock","year":"2011","unstructured":"Decock, J., Thirkettle, S., Wagstaff, L. & Edwards, D. R. Matrix metalloproteinases: Protective roles in cancer. J. Cell. Mol. Med. 15, 1254\u20131265 (2011).","journal-title":"J. Cell. Mol. Med."},{"key":"52354_CR34","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/carcin\/bgp272","volume":"31","author":"AJ Schetter","year":"2010","unstructured":"Schetter, A. J., Heegaard, N. H. H. & Harris, C. C. Inflammation and cancer: Interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis 31, 37\u201349 (2010).","journal-title":"Carcinogenesis"},{"key":"52354_CR35","doi-asserted-by":"publisher","first-page":"3831","DOI":"10.2174\/138161212802083707","volume":"18","author":"DB Vendramini-Costa","year":"2012","unstructured":"Vendramini-Costa, D. B. & Carvalho, J. E. Molecular link mechanisms between inflammation and cancer. Curr. Pharm. Des. 18, 3831\u20133852 (2012).","journal-title":"Curr. Pharm. Des."},{"key":"52354_CR36","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1902\/jop.2006.050293","volume":"77","author":"MS Kumar","year":"2006","unstructured":"Kumar, M. S., Vamsi, G., Sripriya, R. & Sehgal, P. K. Expression of matrix metalloproteinases (MMP-8 and -9) in chronic periodontitis patients with and without diabetes mellitus. J. Periodontol. 77, 1803\u20131808 (2006).","journal-title":"J. Periodontol."},{"key":"52354_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/froh.2022.897115","volume":"3","author":"T Sorsa","year":"2022","unstructured":"Sorsa, T. et al. aMMP-8 oral fluid poc test in relation to oral and systemic diseases. Front. Oral Health 3, 897115 (2022).","journal-title":"Front. Oral Health"},{"key":"52354_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/JCI92035","volume":"127","author":"AR Saltiel","year":"2017","unstructured":"Saltiel, A. R. & Olefsky, J. M. Inflammatory mechanisms linking obesity and metabolic disease. J. Clin. Invest. 127, 1\u20134 (2017).","journal-title":"J. Clin. Invest."},{"key":"52354_CR39","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/j.jacc.2003.12.047","volume":"43","author":"JA Ambrose","year":"2004","unstructured":"Ambrose, J. A. & Barua, R. S. The pathophysiology of cigarette smoking and cardiovascular disease: An update. J. Am. Coll. Cardiol. 43, 1731\u20131737 (2004).","journal-title":"J. Am. Coll. Cardiol."},{"key":"52354_CR40","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/bjc.2016.127","volume":"115","author":"A Jonsson","year":"2016","unstructured":"Jonsson, A., Hjalmarsson, C., Falk, P. & Ivarsson, M.-L. Levels of matrix metalloproteinases differ in plasma and serum \u2013 Aspects regarding analysis of biological markers in cancer. Br. J. Cancer. 115, 703\u2013706 (2016).","journal-title":"Br. J. Cancer."},{"key":"52354_CR41","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ab.2005.04.038","volume":"344","author":"RF Gerlach","year":"2005","unstructured":"Gerlach, R. F., Uzuelli, J. A., Souza-Tarla, C. D. & Tanus-Santos, J. E. Effect of anticoagulants on the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities. Anal. Biochem. 344, 147\u2013149 (2005).","journal-title":"Anal. Biochem."},{"key":"52354_CR42","doi-asserted-by":"publisher","first-page":"5069","DOI":"10.1158\/1078-0432.CCR-05-0774","volume":"11","author":"S Zucker","year":"2005","unstructured":"Zucker, S. & Cao, J. Measurement of matrix metalloproteinases in serum of patients with melanoma: Snarled in technical pitfalls. Clin. Cancer Res. 11, 5069\u20135070 (2005).","journal-title":"Clin. Cancer Res."},{"key":"52354_CR43","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1515\/CCLM.2006.090","volume":"44","author":"K Thrailkill","year":"2006","unstructured":"Thrailkill, K. et al. Physiological matrix metalloproteinase (MMP) concentrations: comparison of serum and plasma specimens. Clin Chem Lab Med 44, 503\u2013504 (2006).","journal-title":"Clin Chem Lab Med"},{"key":"52354_CR44","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1080\/02841860802022976","volume":"47","author":"SO W\u00fcrtz","year":"2008","unstructured":"W\u00fcrtz, S. O., Schrohl, A.-S., Mouridsen, H. & Br\u00fcnner, N. TIMP-1 as a tumor marker in breast cancer--An update. Acta Oncol. 47, 580\u2013590 (2008).","journal-title":"Acta Oncol."},{"key":"52354_CR45","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1161\/ATVBAHA.107.154831","volume":"27","author":"AM Tuomainen","year":"2007","unstructured":"Tuomainen, A. M. et al. Serum matrix metalloproteinase-8 concentrations are associated with cardiovascular outcome in men. Arterioscler. Thromb. Vasc. Biol. 27, 2722\u20132728 (2007).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"52354_CR46","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1161\/ATVBAHA.107.159277","volume":"28","author":"AM Tuomainen","year":"2008","unstructured":"Tuomainen, A. M., Nyyss\u00f6nen, K., Tervahartiala, T., Sorsa, T. & Pussinen, P. J. Matrix metalloproteinase-8 and tissue inhibitor of metalloproteinase-1 in serum do not reflect the analytes circulating in blood. Arterioscler. Thromb. Vasc. Biol. 28, e17\u2013e17 (2008).","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52354-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52354-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52354-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:35:44Z","timestamp":1784763344000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52354-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["52354"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-52354-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"10 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"23048"}}